Mirati Therapeutics has an ever-present need for copyright complaint access to information. The content acquisition process prior to the Covid-19 pandemic was based on both departmental and individual preferences; there wasn’t a single, streamlined approach. This inconsistency created data silos internally and left users without a centralized place to access content and collaborate. Many researchers, out of habit or convenience, were storing content directly on their desktops or personal folders, so ease of sharing, or the ability to know what was already available under Mirati’s licenses, was hindered.
Having a central access point for content was what Romel called “the main benefit” of RightFind Enterprise, Copyright Clearance Center’s (CCC) comprehensive solution to find, manage, and collaborate on content.
And even though they kicked off the implementation process from the kitchen table rather than the office, implementation was able to run on schedule, without adjustments.